Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

King and Palatin to jointly develop, commercialize PT-141

Aug. 18, 2004

Novel small molecule with thrombopoietin mimetic activity

Aug. 18, 2004

New PPAR modulators prepared and evaluated by AstraZeneca team

Aug. 17, 2004

BMS researchers design novel serotonin receptor modulators for use as antiobesity agents

Aug. 17, 2004

Mexican launch for Sucanon planned

Aug. 17, 2004

Chloride channel inhibitor prevents bone resorption in ovariectomized rats

Aug. 17, 2004

Prostaglandin E2 receptor agonist accelerates bone repair in rats

Aug. 17, 2004

Novel PPARdelta agonists and their use in diabetes, dyslipidemia, etc.

Aug. 16, 2004

Teijin claims new vitamin D3 analogues for osteoporosis and other disorders

Aug. 16, 2004

Leptin may regulate energy balance by posttranslational modulation of the melanocortin pathway

Aug. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...